Biosecurity measures in European beekeeping.

Emerging pathogens of honey bees represent an important threat to the development of the beekeeping sector. The implementation of biosecurity measures in beekeeping (BMBs) plays an essential role in supporting honey bee health within the beekeeping sector. A group of experts, in collaboration with the BPRACTICES (Grant Agreement No. 696231, European Research Area on Sustainable Animal Production Systems [ERA-Net SusAn]) project partners, has provided the definition of BMBs. Thus, BMBs are all those operational activities implemented to control the risk of introduction and spread of specific honey bee disease agents. In this paper, the BMBs in the European beekeeping context are identified for the most relevant honey bee diseases in Europe: varroosis, American foulbrood (AFB), European foulbrood (EFB), nosemosis and aethinosis. Moreover, BMBs were classified in â€Ëœcategories' adapted to consider productivity and the â€ËœOne Health' approach: human health, honey bee health and protection of the environment. The 84 BMBs described by the panel of experts were ranked according to the priority score attributed. The implementation of BMBs represents an essential step forwards to increase the resilience and sustainability of European beekeeping.

L'émergence de nouveaux agents pathogènes chez les abeilles mellifères représente une menace importante pour le développement du secteur apicole. La mise en oeuvre de mesures de biosécurité en apiculture est déterminante pour préserver la santé des abeilles mellifères dans les élevages. En collaboration avec des partenaires du projet BPRACTICES (convention de subvention n° 696231, programme ERA-Net SusAn [European Research Area on Sustainable Animal Production Systems]), un groupe d'experts a élaboré un cadre définissant ces mesures de biosécurité. Sont définies comme mesures de biosécurité en apiculture toutes les activités opérationnelles mises en oeuvre pour contrôler le risque d'introduction et de propagation d'agents pathogènes affectant spécifiquement les abeilles mellifères. Les auteurs décrivent les mesures de biosécurité applicables, dans le contexte apicole européen, aux maladies les plus importantes en Europe : la varroose, la loque américaine, la loque européenne, la nosémose et l'infestation par Aethina tumida. En outre, les mesures de biosécurité en apiculture ont été regroupées en « catégories ¼ afin de prendre en compte la productivité et l'approche « Une seule santé ¼ : santé humaine, santé des abeilles mellifères et protection de l'environnement. Les 84 mesures de biosécurité en apiculture décrites par le groupe d'experts ont été classées en fonction du niveau de priorité qui leur a été attribué. La mise en oeuvre de ces mesures représente une étape cruciale pour accroître la résilience et la durabilité de l'apiculture européenne.

Los agentes patógenos emergentes que afectan a la abeja melífera suponen una importante amenaza para el desarrollo del sector apícola. La aplicación de medidas de seguridad biológica dentro de este sector cumple una función esencial para proteger la salud de las abejas. En colaboración con asociados en el proyecto BPRACTICES (acuerdo de subvención nº 696231, programa ERA-Net SusAn [Espacio Europeo de Investigación - «Sistemas sostenibles de producción animal¼]), un grupo de expertos definió las «medidas de seguridad biológica en apicultura¼ como todas aquellas acciones realizadas para controlar el riesgo de penetración y propagación de agentes patógenos de la abeja melífera. Los autores, situándose en el contexto de la apicultura europea, exponen las medidas de seguridad biológica que ayudan a controlar las principales enfermedades de la abeja melífera en Europa: varroosis, loque americana, loque europea, nosemosis y aethinosis (infestación por el escarabajo de las colmenas). Por otra parte, estas medidas fueron divididas en diferentes «categorías¼ para poder tener en cuenta las cuestiones de productividad y el enfoque de «Una sola salud¼: salud humana, salud de la abeja melífera y protección del medio ambiente. Las 84 medidas de seguridad biológica en apicultura que describió el cuadro de expertos fueron jerarquizadas en función de una puntuación atribuida por su nivel de prioridad. La aplicación de este tipo de medidas representa un crucial paso adelante para conferir más resiliencia a la apicultura europea y hacerla más sostenible.

Good farming practices in apiculture.

Modern European beekeeping is facing numerous challenges due to a variety of factors, mainly related to globalisation, agrochemical pollution and environmental changes. In addition to this, new pathogens threaten the health of European honey bees. In that context, correct colony management should encompass a wider vision, where productivity aspects are linked to a One Health approach in order to protect honey bees, humans and the environment. This paper describes a novel tool to be applied in beekeeping operations: good beekeeping practices (GBPs). The authors ranked a list of GBPs scored against their importance and validated by an international team, including researchers, national animal health authorities and international beekeepers' associations. These activities were carried out in the project 'BPRACTICES', approved within the transnational call of the European Research Area Network on Sustainable Animal Production (ERA-NET SusAn) in the Horizon 2020 Research and Innovation Programme of the European Union. This study, created through an international collaboration, aims to present an innovative and implementable approach, similar to applications already adopted in other livestock production systems.

L'apiculture moderne européenne est confrontée à de nombreuses difficultés dues à divers facteurs, pour la plupart liés à la mondialisation, à la pollution agrochimique et à la modification de l'environnement. À ces facteurs s'ajoute l'émergence de nouveaux agents pathogènes qui menacent la santé des abeilles mellifères d'Europe. Dans ce contexte, une gestion appropriée des colonies d'abeilles devrait reposer sur une vision plus large, dans laquelle les aspects relevant de la productivité sont examinés suivant une approche « Une seule santé ¼ afin de protéger les abeilles mellifères, les humains et l'environnement. Les auteurs décrivent un nouvel outil destiné à l'apiculture : les bonnes pratiques apicoles. Ils ont évalué et classé par ordre d'importance une liste de bonnes pratiques apicoles validées par une équipe internationale composée de chercheurs, d'autorités nationales de la santé animale et d'associations internationales d'apiculteurs. Ces activités ont été conduites dans le cadre du projet « BPRACTICES ¼, proposition retenue suite à l'appel à projets transnationaux du réseau ERA­NET SusAn (European Research Area Network on Sustainable Animal Production) au sein du Programme Horizon 2020 de l'Union européenne pour la recherche et l'innovation. Conçue sous forme de collaboration internationale, cette étude vise à proposer une approche innovante et pratique, similaire aux applications précédemment adoptées dans d'autres systèmes de production animale.

La apicultura europea hace frente a numerosos problemas resultantes de diversos factores, relacionados principalmente con la mundialización, la contaminación agroquímica y los cambios ambientales, a todo lo cual se suman nuevos patógenos que amenazan la salud de las abejas melíferas europeas. En este contexto, una correcta gestión de las colonias debe traer aparejada una visión más global, en la que las cuestiones de productividad se consideren en clave de «Una sola salud¼ con objeto de proteger tanto a las abejas melíferas como a las personas y el medio ambiente. En este artículo se describe una novedosa herramienta aplicable a la actividad apícola: las buenas prácticas de apicultura. Los autores jerarquizaron una serie de buenas prácticas de apicultura seleccionadas, validadas y puntuadas según su importancia por un equipo internacional que incluía a investigadores, autoridades nacionales de sanidad animal y asociaciones internacionales de apicultores. Este trabajo formaba parte del proyecto «BPRACTICES¼, aprobado con ocasión de la convocatoria internacional abierta por la Red del espacio europeo de investigación en sanidad animal sostenible (ERA­NET SusAn), inscrita a su vez en Horizonte 2020, el programa de investigación e innovación de la Unión Europea. El estudio aquí descrito, fruto de la colaboración internacional, tiene por objeto presentar un planteamiento novedoso y viable, parecido a las aplicaciones ya implantadas en otros sistemas de producción animal.

Topical lactoferrin can improve stable psoriatic plaque.

AIM: Lactoferrin (LF), a non-haem iron binding glycoprotein, shares antimicrobial properties with innate immune system components influencing proinflammatory release of cytokines involved in psoriatic plaque development. The objective of the study was to verify if LF could provide a therapeutic application in psoriasis. METHODS: An open-label, two arms, 4-week trial was designed on 30 subjects affected by mild to moderate plaque psoriasis. All patients received oral bovine LF 100 mg. Fifteen patients (group A) were topically treated with 10% LF ointment, 15 patients (group B) with 20% LF ointment. All patients applied only ointment vehicle on contra lateral target lesion as intra-patient side to side control. Efficacy was assessed by Target Lesion Score. RESULTS: Twenty-two patients completed the study. Improvement in elevation, redness and scaling was observed on LF treated psoriatic target lesions comparing to the controlateral controls (P<0.05). There was no additional efficacy for 20% versus 10% topical applications. Oral drug alone did not exert any improvement on the control plaques receiving topical placebo. CONCLUSION: Our clinical results suggest that LF could be included as a possible safe topical therapeutic option in the treatment of psoriatic plaque.

Lactoferrin efficacy versus ferrous sulfate in curing iron disorders in pregnant and non-pregnant women.

Iron homeostasis in pregnancy compensates for increased iron requirements and in women of child-bearing age for iron loss in menses. Oral administration of ferrous sulfate, prescribed to cure iron deficiency (ID) and ID anemia (IDA), often fails to increase hematological parameters and causes adverse effects. Recently, we demonstrated safety and efficacy of bovine lactoferrin (bLf) in pregnant women suffering from ID/IDA. Two clinical trials were conducted on pregnant and non-pregnant women of child-bearing age suffering from ID/IDA. In both trials, women received oral administration of bLf 100 mg/twice/day (Arm A), or ferrous sulfate 520 mg/day (Arm B). Hematological parameters, serum IL-6 and prohepcidin were assayed before and after therapy. Unlike ferrous sulfate, bLf increased hematological parameters (P less than 0.0001). In pregnant women, bLf decreased serum IL-6 (P less than 0.0001), and increased prohepcidin (P=0.0007). In non-pregnant women bLf did not change the low IL-6 levels while it increased prohepcidin (P less than 0.0001). Ferrous sulfate increased IL-6 (P less than 0.0001) and decreased prohepcidin (P=0.093). bLf established iron homeostasis by modulating serum IL-6 and prohepcidin synthesis, whereas ferrous sulfate increased IL-6 and failed to increase hematological parameters and prohepcidin. bLf is a more effective and safer alternative than ferrous sulfate for treating ID and IDA.

Bone metastases from squamous cell carcinoma of the head and neck.

BACKGROUND AND OBJECTIVES: Carcinoma of the head and neck is an uncommon primary source of bone metastases. The increasing duration of survival of these patients, however, increases the probability of late bone involvement. The objective was to identify the frequency, clinical presentation, and clinical course of metastatic disease to bone from head and neck primaries. METHODS: A retrospective review was accomplished of the radiographs and nuclear medicine studies for 363 cases of squamous cell carcinoma of the head and neck for whom radiologic studies had been performed. For those with identified bone involvement, a chart review was performed to identify clinical presentation, disease course, and outcome. RESULTS: Only approximately 1% of these patients had clinically demonstrable bone metastases. Eight sites of bone involvement were identified in five patients, including three pelvic, two femoral, and one each humeral, rib, and thoracic spine lesions. All lesions were purely lytic with moth-eaten or permeative borders. Time from primary tumor diagnosis to identification of metastatic disease ranged from being present at diagnosis to a maximum 3.5 years later. Time from identification of metastatic disease to patient death was no greater than 8 months. CONCLUSIONS: Despite the increasing overall survival of patients with these carcinomas, distant bone metastases are infrequent, but should be considered a possibility in any patient with a concurrent or past diagnosis of head and neck carcinoma. The very short time from discovery of bone dissemination to death in most of these patients should be taken into consideration when contemplating operative intervention.

Intramedullary screw fixation of Jones fractures: a biomechanical study.

The management of proximal fifth metatarsal ("Jones") fractures in athletes has become increasingly more aggressive, despite a lack of biomechanical data in the literature. A cadaver biomechanical study was conducted to evaluate the strength of intramedullary fixation of simulated Jones fractures loaded to failure via three-point bending on a Materials Testing System machine. In a series of eight intact fifth metatarsal control specimens, the force to failure (fracture) was measured for comparison with repaired specimens. Acute fractures were simulated in 10 pairs of feet via osteotomy at the typical fracture location and were fixed with either a 4.5-mm malleolar screw or a 4.5-mm partially threaded, cancellous, cannulated screw, both placed using conventional intramedullary techniques. Force at initial displacement averaged 73.9 N (SD, 64.7 N) for the malleolar screws and 72.5 N (SD, 42.3 N) for the cannulated screws. Force at complete displacement averaged 519.3 N (SD, 226.2 N) for the malleolar screws and 608.4 N (SD, 179.7 N) for the cannulated screws. The force to failure of the intact specimens was significantly greater than the initial and complete forces to failure for the fixed specimens (P < 0.05, independent measures analysis of variance). There was no statistical difference between the average forces at initial displacement or at complete displacement in the fixed metatarsal specimens for the two different types of screws, but the forces at complete displacement for each screw type were significantly greater than the forces at initial displacement (P < 0.05). On the basis of literature review and data generated from this study, it is apparent that the forces necessary to cause displacement of the stabilized Jones fracture are above what would be transmitted within the lateral midfoot during normal weightbearing. The choice of screw and intramedullary technique of fixation is a matter of surgeon preference, because the choice of screw makes no biomechanical difference.